Vikas Khemani of Carnelian Capital Advisors discusses the expansion potential of the pharma sector and the optimistic outlook for IT companies like TCS and Infosys. He believes that the underperformance of pharma over the previous seven to eight years is …

Vikas Khemani of Carnelian Capital Advisors discusses the expansion potential of the pharma sector and the optimistic outlook for IT companies like TCS and Infosys. He believes that the underperformance of pharma over the previous seven to eight years is …

Vikas Khemani of Carnelian Capital Advisors discusses the expansion potential of the pharma sector and the optimistic outlook for IT companies like TCS and Infosys. He believes that the underperformance of pharma over the previous seven to eight years is …